Physician

Ashish Dalal, MD

According to 2025 Medicare claims, Ashish Dalal, MD (NPI: 1801857966) practices hematology/oncology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is HEALTH FIRST MEDICAL GROUP, LLC (NPI: 1750626495; TIN: 461243081) and primary practice location at 32940-2240. Dalal is affiliated with the Privia Quality Network Central Florida, LLC (ACO ID: A4947), participating under the MSSP model.

Dalal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,477 traditional Medicare patients, billed 374,962 HCPCS/CPT codes, and received $5,690,722 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,456 prescription claims across 334 beneficiaries totaling $5,658,037 in drug costs, led by Xtandi (Enzalutamide). DME data shows 14 claims. Open Payments data shows 3 records totaling $67. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,795,510 to $5,690,722. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,369,346 to $5,658,037. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,089	150,461	$1,795,510
2016	1,152	260,162	$3,117,986
2017	1,175	291,755	$3,941,642
2018	1,254	329,209	$4,536,075
2019	1,277	312,299	$4,564,902
2020	1,169	361,111	$6,324,448
2021	1,143	345,397	$5,428,347
2022	1,315	329,992	$6,194,972
2023	1,441	369,028	$6,110,349
2024	1,477	374,962	$5,690,722

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	199	1,228	$1,369,346
2016	246	1,501	$2,222,273
2017	281	1,489	$2,426,853
2018	282	1,652	$3,081,928
2019	290	1,517	$2,823,131
2020	300	1,789	$3,602,407
2021	300	1,581	$3,712,232
2022	296	1,715	$4,347,190
2023	299	1,456	$4,703,867
2024	334	1,456	$5,658,037

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	94	$25,127
2016	N/R	106	$25,044
2017	N/R	40	$7,647
2018	N/R	78	$13,196
2019	N/R	64	$6,454
2020	N/R	72	$5,308
2021	N/R	15	$243
2022	N/R	52	$1,344
2023	N/R	53	$2,294
2024	N/R	14	$176

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	222	487	$138
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	210	210	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	719	1,746	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	585	938	$64
96372	Injection of drug or substance under skin or into muscle	222	672	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	59	1,770	$824,123
Verzenio	Abemaciclib	44	1,232	$636,567
Brukinsa	Zanubrutinib	31	912	$462,871
Lenalidomide	Lenalidomide	27	756	$437,045
Imbruvica	Ibrutinib	29	812	$433,249

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	14	$176

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$67	PharmaEssentia USA Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ashish Dalal, MD?

Tedicare shows public-source Medicare data for Ashish Dalal, MD (NPI 1801857966), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashish Dalal, MD have ACO affiliation data?

Ashish Dalal, MD is shown with ACO affiliation data for Privia Quality Network Central Florida, LLC (MSSP, ACO ID A4947).

What billing organization is linked to Ashish Dalal, MD?

Ashish Dalal, MD is linked to HEALTH FIRST MEDICAL GROUP, LLC (billing NPI 1750626495) in the available physician profile data.

Does Ashish Dalal, MD have Open Payments data?

Ashish Dalal, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.